Literature DB >> 18534743

Prevalence of atrial septal abnormalities in older patients with cryptogenic ischemic stroke or transient ischemic attack.

M Force1, P Massabuau, V Larrue.   

Abstract

OBJECTIVE: To evaluate the association of atrial septal abnormalities--patent foramen ovale (PFO), atrial septal aneurysm (ASA), or the combination of both (PFO+ASA)--with cryptogenic stroke or transient ischemic attack (TIA) in older patients.
METHODS: We examined the prevalences of PFO, ASA, and PFO+ASA in 132 consecutive patients aged 55 years or more who underwent transesophageal echocardiography (TEE) for evaluation of ischemic stroke or TIA. We compared patients with cryptogenic stroke/TIA and those with stroke/TIA of known cause.
RESULTS: PFO+ASA was more common in patients with cryptogenic stroke/TIA than in patients with stroke/TIA of known cause (12/62 or 19% vs. 2/70 or 3%; adjusted odds ratio, 7.4; 95% CI, 1.4-38.2). Differences between groups for isolated PFO, and isolated ASA were not significant. The association of PFO+ASA with cryptogenic stroke/TIA was confirmed in the subgroup of patients aged 75 years or more (odds ratio, 15.0; 95% CI, 1.5-146.7).
CONCLUSION: This study indicates a significant association of PFO+ASA with cryptogenic stroke or TIA in older patients.

Entities:  

Mesh:

Year:  2008        PMID: 18534743     DOI: 10.1016/j.clineuro.2008.04.012

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  7 in total

1.  The Role of Patent Foramen Ovale in Cryptogenic Stroke.

Authors:  Songül Şenadim; Dilek Bozkurt; Murat Çabalar; Arsida Bajrami; Vildan Yayla
Journal:  Noro Psikiyatr Ars       Date:  2016-03-01       Impact factor: 1.339

2.  Prevalence of patent foramen ovale in ischemic stroke in Italy: the SISIFO study.

Authors:  Domenico Consoli; Maurizio Paciaroni; Marco Aguggia; Maurizio Melis; Giovanni Malferrari; Simone Vidale; Paolo Cerrato; Simona Sacco; Carlo Gandolfo; Paolo Bovi; Carlo Serrati; Massimo Del Sette; Anna Cavallini; Marina Diomedi; Paolo Postorino; Stefano Ricci
Journal:  Neurol Sci       Date:  2014-01-01       Impact factor: 3.307

Review 3.  The brain's heart - therapeutic opportunities for patent foramen ovale (PFO) and neurovascular disease.

Authors:  Mingming Ning; Eng H Lo; Pei-Chen Ning; Su-Yu Xu; David McMullin; Zareh Demirjian; Ignacio Inglessis; G William Dec; Igor Palacios; Ferdinando S Buonanno
Journal:  Pharmacol Ther       Date:  2013-03-23       Impact factor: 12.310

4.  Prevalence of patent foramen ovale in cryptogenic transient ischaemic attack and non-disabling stroke at older ages: a population-based study, systematic review, and meta-analysis.

Authors:  Sara Mazzucco; Linxin Li; Lucy Binney; Peter M Rothwell
Journal:  Lancet Neurol       Date:  2018-06-07       Impact factor: 59.935

5.  Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale: analysis of putative high-risk features from the risk of paradoxical embolism database.

Authors:  Benjamin S Wessler; David E Thaler; Robin Ruthazer; Christian Weimar; Marco R Di Tullio; Mitchell S V Elkind; Shunichi Homma; Jennifer S Lutz; Jean-Louis Mas; Heinrich P Mattle; Bernhard Meier; Krassen Nedeltchev; Federica Papetti; Emanuele Di Angelantonio; Mark Reisman; Joaquín Serena; David M Kent
Journal:  Circ Cardiovasc Imaging       Date:  2013-11-08       Impact factor: 7.792

6.  Transesophageal echocardiography in patients with cryptogenic cerebral ischemia.

Authors:  Fabian Knebel; Florian Masuhr; Wolfram von Hausen; Torsten Walde; Henryk Dreger; Vanessa Raab; Mahsun Yuerek; Gert Baumann; Adrian C Borges
Journal:  Cardiovasc Ultrasound       Date:  2009-03-28       Impact factor: 2.062

Review 7.  Patent foramen ovale, ischemic stroke and migraine: systematic review and stratified meta-analysis of association studies.

Authors:  Daniel Davis; John Gregson; Peter Willeit; Blossom Stephan; Rustam Al-Shahi Salman; Carol Brayne
Journal:  Neuroepidemiology       Date:  2012-10-11       Impact factor: 3.282

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.